期刊文献+

胆固醇氧化衍生物在动脉粥样硬化中的研究进展 被引量:2

Research on cholesterol oxidation derivative in Atherosclerosis
下载PDF
导出
摘要 胆固醇氧化衍生物多达上百种。具有代表性质的胆固醇氧化衍生物主要有7-酮基胆固醇、7-酮基胆甾醇-9-羧基壬酸酯、25-羟基胆固醇、7β-羟基胆固醇、3β,5α,6β-三羟基胆固烷等化合物,这些衍生物广泛存在于胆固醇膳食、高胆固醇血症的血浆、动脉组织、人动脉粥样硬化斑块、斑块内的泡沫细胞、以及氧化型低密度脂蛋白中。大量实验表明胆固醇氧化衍生物对动脉粥样硬化形成有关因素(炎症、氧化应激、凋亡)具有促进作用。提示,胆固醇氧化衍生物在动脉粥样硬化的发生和发展中具有重要的作用。 Cholesterol oxidation derivatives are as many as one hundred kinds. The 7-ketocholesterol, 7-ketocholesteryl- 9-carboxynonanoate, 25-hydroxycholesterol, 7β-hydroxycholesterol and cholest-3β,5α,6β-triol are representatives of cholesterol oxidation derivatives. They are found in the foodstuffs, the blood and arterial tissues of animals with hypercholesterolemia, the human atheroma, the foam cell from atherosclerotic tissues as well as in the oxidized low density lipoprotein. The results of experiments have demonstrated that cholesterol oxidation derivatives are cytotoxic and correlate to a variety of factors of atherosclerosis including inflammation, oxidative stress, apoptosis suggesting that cholesterol oxidation derivative could play a key role in the initiation and pathogenesis of atherosclerosis.
出处 《大连大学学报》 2008年第3期79-83,共5页 Journal of Dalian University
基金 国家自然科学基金(30371380 30571733)
关键词 胆固醇氧化衍生物 动脉粥样硬化 7-酮胆固醇 7-酮基胆甾醇-9-羧基壬酸酯 cholesterol oxidation derivative atherosclerosis 7-ketocholesterol 7-ketocholesteryl-9-carboxynonanoate
  • 相关文献

参考文献27

  • 1[1]BROOKS C,HARLAND W,STEEL G.26-hydroxycholesterol and 7-ketocholesterol in human atheromatous plaques[J].Biochem.Biophys.Acta,1966,125(3):620-622.
  • 2[2]KRITCHEVSKYD,MARCUCCIA,SALLATAP.Comparison of amorphous and crystalline cholesterol in establishment of atherosclerosis in rabbits[J].Med.Exp.Int.,1969,19(4):185-93.
  • 3[3]GUARDIOLA F,CODONY R,ADDIS PB,et al.Biological effects of oxysterols[J].Food Chem.Toxicol.,1996,34:93-211.
  • 4[4]LIU Q,KOBAYASHI K,FURUKAWA J.ω-Carboxyl variants of 7-ketocholesteryl esters are ligands for β2-glycoprotein Ⅰ and mediate antibody dependent uptake of oxidized LDL by macrophages[J].Journal of lipid research,2002,43:1486-1495.
  • 5[5]GLASS C K,WITZTUM J L.The road ahead[J].Atherosclerosis,2001,104(4):503-516.
  • 6[6]CLARE K,HARWICK S J,CARPENTER K L,et al.Toxicity of oxysterols to human Monocyte-macrophages[J].Atherosclerosis,1995,118:67-75.
  • 7[7]HAYDEN J,BRACHOVA K,HIGGINS L.Induction of monocyte differentiation and foam cell formation in vitro by 7-ketocholesterol[J].Lipid Res.,2002,43:26-35.
  • 8[8]KOBAYASHI K,LOPEZ L R,SHOENFELD Y,et al.The role of innate and adaptive immunity to oxidized low-density lipoprotein in the development of atherosclerosis[J].Ann.N.Y.Acad.Sci.,2005,1051:442-454.
  • 9[9]AMES P,DELGADO A,LOPEZ L,et al.Antibodies against β-glycoprotein Ⅰ complexed with an oxidised lipoprotein relate to intima thickening of carotid arteries in primary antiphospholipid syndrome[J].Clin.Dev.Immunol.,2006,13(1):1-9.
  • 10[10]MATSUURA E,KOBAYASHI K,KASAHAR A.Anti-β2-glycoprotein 1 autoantibodies and atherosclerosis[J].Int.Rev.Immunol.,2002,21(1):51-66.

同被引文献9

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部